Literature DB >> 23374259

The cutaneous innate immune response in patients with atopic dermatitis.

I-Hsin Kuo1, Takeshi Yoshida, Anna De Benedetto, Lisa A Beck.   

Abstract

Orchestrating when and how the cutaneous innate immune system should respond to commensal or pathogenic microbes is a critical function of the epithelium. The cutaneous innate immune system is a key determinant of the physical, chemical, microbial, and immunologic barrier functions of the epidermis. A malfunction in this system can lead to an inadequate host response to a pathogen or a persistent inflammatory state. Atopic dermatitis is the most common inflammatory skin disorder and characterized by abnormalities in both skin barrier structures (stratum corneum and tight junctions), a robust T(H)2 response to environmental antigens, defects in innate immunity, and an altered microbiome. Many of these abnormalities may occur as the consequence of epidermal dysfunction. The epidermis directly interfaces with the environment and, not surprisingly, expresses many pattern recognition receptors that make it a key player in cutaneous innate immune responses to skin infections and injury. This review will discuss the role epidermal innate receptors play in regulation of skin barriers and, where possible, discuss the relevance of these findings for patients with atopic dermatitis.
Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23374259     DOI: 10.1016/j.jaci.2012.12.1563

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  63 in total

1.  Exacerbation of allergen-induced eczema in TLR4- and TRIF-deficient mice.

Authors:  Eric B Brandt; Aaron M Gibson; Stacey Bass; Carolyn Rydyznski; Gurjit K Khurana Hershey
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

Review 2.  The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells.

Authors:  William R Heath; Francis R Carbone
Journal:  Nat Immunol       Date:  2013-09-18       Impact factor: 25.606

Review 3.  The Skin as a Route of Allergen Exposure: Part II. Allergens and Role of the Microbiome and Environmental Exposures.

Authors:  George Knaysi; Anna R Smith; Jeffrey M Wilson; Julia A Wisniewski
Journal:  Curr Allergy Asthma Rep       Date:  2017-01       Impact factor: 4.806

Review 4.  Atopic dermatitis in children: clinical features, pathophysiology, and treatment.

Authors:  Jonathan J Lyons; Joshua D Milner; Kelly D Stone
Journal:  Immunol Allergy Clin North Am       Date:  2014-11-21       Impact factor: 3.479

5.  Epidermal tight junctions in health and disease.

Authors:  J M Brandner; M Zorn-Kruppa; T Yoshida; I Moll; L A Beck; A De Benedetto
Journal:  Tissue Barriers       Date:  2015-04-03

Review 6.  Tight junctions in skin inflammation.

Authors:  Katja Bäsler; Johanna M Brandner
Journal:  Pflugers Arch       Date:  2016-11-16       Impact factor: 3.657

7.  Association between atopic dermatitis and serious cutaneous, multiorgan and systemic infections in US adults.

Authors:  Shanthi Narla; Jonathan I Silverberg
Journal:  Ann Allergy Asthma Immunol       Date:  2018-01       Impact factor: 6.347

8.  Malassezia Yeast and Cytokine Gene Polymorphism in Atopic Dermatitis.

Authors:  Charu Jain; Shukla Das; V G Ramachandran; Rumpa Saha; S N Bhattacharya; Sajad Dar
Journal:  J Clin Diagn Res       Date:  2017-03-01

Review 9.  The role of innate immune signaling in the pathogenesis of atopic dermatitis and consequences for treatments.

Authors:  Yuliya Skabytska; Susanne Kaesler; Thomas Volz; Tilo Biedermann
Journal:  Semin Immunopathol       Date:  2015-11-16       Impact factor: 9.623

10.  Guanine nucleotide exchange factor RABGEF1 regulates keratinocyte-intrinsic signaling to maintain skin homeostasis.

Authors:  Thomas Marichal; Nicolas Gaudenzio; Sophie El Abbas; Riccardo Sibilano; Oliwia Zurek; Philipp Starkl; Laurent L Reber; Dimitri Pirottin; Jinah Kim; Pierre Chambon; Axel Roers; Nadine Antoine; Yuko Kawakami; Toshiaki Kawakami; Fabrice Bureau; See-Ying Tam; Mindy Tsai; Stephen J Galli
Journal:  J Clin Invest       Date:  2016-11-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.